The information in this article is not intended as, and should not be taken as, medical advice. Interventions like exercising, dietary changes, and taking medications and supplements can have both benefits and side effects, Please consult with a medical professional about any medical concerns. See full Medical Disclaimer

by Nils Osmar

What the research actually shows about avocados, longevity, and heart health — including some surprises about leukemia, sirtuin genes, and oxalates.

Few foods have been promoted as enthusiastically as the avocado over the past decade. Heart-healthy. Anti-inflammatory. A “longevity superfood.” A potent leukemia-fighter. But how much of this holds up under scrutiny? Some of it does. Some of it is more complicated than the headlines suggest. And a few claims rest on shaky ground.

This article is an honest tour through what the research currently supports, what it doesn’t, and how to think about avocados in a serious longevity practice.

Oleic Acid and the Sirtuins

Avocados are roughly 67 to 71 percent oleic acid by lipid content — the same monounsaturated fat that makes olive oil famous. One popular claim, often associated with Dr. David Sinclair, is that oleic acid activates SIRT1, one of the seven mammalian sirtuin enzymes implicated in aging biology.

That part is true. A 2013 paper in the Journal of Biological Chemistry showed that oleic acid stimulates the cAMP/PKA pathway, which phosphorylates SIRT1 and increases its deacetylase activity, particularly at PGC-1α — a master regulator of mitochondrial biogenesis. A 2020 systematic review in Advances in Nutrition concluded that oleic acid is the best-characterized natural activator of SIRT1.

But the more interesting finding — and one that’s underemphasized in popular longevity coverage — is what oleic acid does to SIRT6.

The Sirtuin Actually Associated with Longevity in Mammals

SIRT6 is the sirtuin with the strongest mammalian longevity data. Transgenic mice overexpressing SIRT6 live significantly longer (about 15 percent in males in the original 2012 Nature study; both sexes in a 2021 Nature Communications follow-up).

When researchers crossed SIRT1 and SIRT6 overexpression in mice, SIRT1 added nothing on top of SIRT6 alone. (There was no increase in longevity.) SIRT6 is also the sirtuin most clearly implicated in DNA repair, genomic stability, and the suppression of glycolytic and lipogenic gene expression — all hallmarks of aging biology.

So contrary to David Sinclair’s assertions, the activation of the SIRT

1 gene is not associated with life extension. But. a separate 2013 paper in the Journal of Biological Chemistry (Feldman et al.) demonstrated that oleic acid is a direct SIRT6 activator. The mechanism is structural, not related to signaling. Oleic acid binds to a hydrophobic pocket near SIRT6’s acyl channel and produces up to a 35-fold increase in catalytic efficiency for histone deacetylation.

Critically, this activation is specific to SIRT6, not SIRT1. Multiple follow-up papers have confirmed the finding (a 2016 study in PMC4813509 used oleic acid as a positive control among “known SIRT6 activators”; a 2021 review in the Journal of Medicinal Chemistry called this connection “fascinating” and proposed that SIRT6 may act as a fatty-acid sensor that translates metabolic signals into epigenetic responses).

So oleic acid activates both sirtuins, through different mechanisms — SIRT1 via PKA-mediated phosphorylation, SIRT6 via direct binding. And SIRT6 is the one with the longevity data.

This materially strengthens the case for monounsaturated fats in a longevity diet — though it requires honest caveats. The strongest evidence comes from in vitro biochemical assays at controlled concentrations. A 2017 paper found that nitro-oleic acid (a metabolite formed during inflammation) produced measurable SIRT6-mediated H3K9 deacetylation in cells, while plain oleic acid did not — suggesting that free oleic acid is rapidly esterified into other lipid species inside cells, possibly limiting how much actually reaches SIRT6 in vivo. The EC50 values from purified-enzyme studies are around 90 to 100 micromolar — physiologically reachable, but only with sustained high intake. And we don’t yet have direct evidence in humans that dietary oleic acid intake produces measurable SIRT6 activation in tissue.

The honest synthesis: the biochemical case for oleic acid as a sirtuin activator is genuine and applies to both SIRT1 (relevant, perhaps, to healthspan) and SIRT6 (the lifespan-relevant sirtuin in mammals). Direct human evidence that dietary intake translates to measurable sirtuin activation in our species is still missing, and the cellular evidence is mixed. But mechanistically, this is one of the more plausible threads connecting Mediterranean-style diets (consistently rich in oleic acid from olive oil and avocados) to their well-established longevity associations.

Calling avocados a longevity food specifically because of sirtuin activation goes beyond what we can prove in humans. Calling them a longevity-plausible food with multiple converging biochemical mechanisms — that’s defensible.

For people serious about supporting SIRT6 specifically, the broader evidence-based picture also includes: NAD+ availability (NMN, NR, niacin), fasting and caloric restriction, intense physical exercise, certain polyphenols (quercetin from onions and apples; gallic acid from berries; EGCG from green tea), and cyanidin from dark berries. Oleic acid sits in this neighborhood as one component, not a magic bullet.

Heart Health: What the Biggest Trial Actually Found

This is the area where the gap between popular claims and rigorous evidence is widest, and the gap is genuinely instructive.

The Habitual Diet and Avocado Trial (HAT), published in 2022 in the Journal of the American Heart Association, is the largest randomized controlled trial of avocados ever conducted: 1,008 adults with abdominal obesity, randomized to either one avocado per day for six months or their habitual diet. This is exactly the kind of study you want before making confident health claims.

The headline result was unexpected to many: daily avocado consumption did not significantly reduce visceral adiposity (the primary outcome), hepatic fat fraction, body weight, BMI, insulin, hsCRP, or most components of metabolic syndrome compared to the control group. A subsequent ancillary study published in 2024 found no improvement in flow-mediated dilation or arterial stiffness either — the gold-standard markers of vascular function.

What did improve, modestly: total cholesterol and LDL-C dropped slightly in the avocado group. Diet quality scores rose. Sleep health scores improved. And in observational data from large U.S. cohorts, people who replaced butter, margarine, processed meats, cheese, and eggs with avocado had measurably lower cardiovascular disease risk over decades.

The honest synthesis is that avocados appear to be heart-healthy primarily as a replacement food for unhealthy fats. When simply added to an existing diet, the effects on hard cardiovascular endpoints are modest at best. The phytosterols (avocados are the richest fruit source of beta-sitosterol — about 38 mg per 50 g), the soluble fiber (3.3 g per fruit), and the displacement of saturated fat all contribute to the LDL effect. The carotenoid-absorption boost from avocado fat is well-documented (a classic study showed lycopene absorption from salsa increased about 4-fold when avocado was added).

This is real, but it’s a different story than “avocados protect your heart.”

Avocados and Leukemia: What’s True, What’s Hyped, What’s Recent

The avocado-leukemia research is more interesting than most reporting suggests, and the timeline matters.

The original discovery came from Paul Spagnuolo’s lab at the University of Waterloo, published in Cancer Research in 2015. The compound is avocatin B (AvoB) — actually a 1:1 mixture of two 17-carbon polyhydroxylated fatty alcohols called avocadyne and avocadene. The mechanism is elegant: AvoB selectively targets leukemia stem cells by inhibiting fatty acid oxidation in their mitochondria, triggering reactive-oxygen-species-dependent cell death. Critically, normal hematopoietic stem cells don’t have the same mitochondrial dependency, so they’re spared. EC50 values in primary AML cells were 1.5 to 5 micromolar, with no toxicity to healthy peripheral blood stem cells even at 20 micromolar.

This was rigorous early-stage work in a top-tier oncology journal. Since then:

2019: Spagnuolo’s group at the University of Guelph published a Molecular Nutrition and Food Research paper showing AvoB also improves insulin sensitivity in mouse models of obesity-induced diabetes, and ran a Phase 1 safety trial in humans for that indication. AvoB was well-tolerated, absorbed into the bloodstream without organ toxicity.
2020: AvoB began commercial sale as a nutraceutical (AvoMax, through SP Nutraceuticals) for metabolic effects, after Health Canada approval as a supplement.
February 2025: A new paper in Nutrition and Cancer showed AvoB slowed leukemia relapse in mouse AML models and supported a 58 percent recovery of healthy stem cells in bone marrow that had been damaged by a high-fat diet. This is the most recent leukemia-specific finding.

What has not happened: a Phase 1 clinical trial of AvoB for leukemia in humans. The 2015 announcement said clinical trials were “years away,” and ten years later they haven’t begun for cancer indications. The diabetes/obesity Phase 1 was completed; cancer translation has been slower than initial press releases suggested.

Fruit or Seed?

Is Avocatin B in the fruit or just the seed? Both. It was first discovered in seeds, but a 2018 LC-MS analytical paper from Spagnuolo’s own group confirmed measurable amounts in the pulp as well. However, levels vary widely between individual avocados, and Spagnuolo himself has stated publicly that “eating avocados alone would likely be ineffective” for therapeutic purposes — the dose is too inconsistent and probably too low. AvoB supplements were developed precisely because dietary intake can’t deliver pharmacological doses reliably.

Has the leukemia finding been replicated independently? Mostly within the Spagnuolo group’s expanding line of work. The original 2015 mechanism has held up — subsequent papers from other labs cite it as established — but independent replication of the in vivo effects in AML by groups outside the Spagnuolo network is limited. The 2025 mouse paper is encouraging but still preclinical and still primarily from the same research lineage.

The honest summary: AvoB’s effects on leukemia are a real mechanistic discovery with a credible target (mitochondrial vulnerability of leukemia stem cells, which is a serious, active area of cancer research). The supplement is of greater interest here than the possible benefits of eating avocados.

Setting Aside Leukemia for a Moment…

Avocatin B acts as a fatty acid oxidation (FAO) inhibitor, and some studies suggests that it does have potential for managing metabolic health. It has been found to improve insulin sensitivity, support healthy blood sugar regulation, and reduce weight gain associated with high-fat diets

Avocado vs. Avocado Oil: What Transfers, What Doesn’t

All of this lead us to a question: if we want the health benefits of avocados, can we skip the fruit and just use the oil?

Avocado oil retains the fatty-acid profile (56 to 77 percent oleic acid), the phytosterols, vitamin E (2.8 to 4.0 mg per tablespoon), and a meaningful amount of carotenoids (mainly lutein, important for eye health). The carotenoid-absorption-enhancing effect when paired with other vegetables is preserved — this is mostly a property of the fat itself.

What’s lost: the fiber (avocado oil has zero), most of the potassium, magnesium, B vitamins, and folate. The polyphenol content is substantially lower than in extra virgin olive oil.

AvoB is a polyhydroxylated fatty alcohol; it’s not present in standard cold-pressed avocado oil in any meaningful quantity (different extraction targets different lipid fractions).

For salad dressings, finishing oils, or moderate-heat cooking — high-quality cold-pressed extra virgin avocado oil is reasonable. The smoke point is high (around 480°F for refined).

Most commercial avocado oil is junk

One genuine caveat: a 2020 UC Davis study found that the majority of avocado oil sold in U.S. supermarkets was either rancid or adulterated with cheaper oils. Look for transparent third-party testing, dark glass bottles, harvest dates close to purchase, and a fresh grassy smell.

Avocado oil could well be a substitute for whole avocados, if you are certain that it is fresh and unadulterated. But if you are eating avocados for the fiber, you need the actual fruit.

Carbohydrates and Low-Carb Diets

Avocados are unusual among fruits in being almost carb-free in the way that matters metabolically. A medium California Hass avocado contains about 11.6 g of total carbohydrates — but 9.1 g of that is fiber, leaving roughly 2.5 g of net carbs per whole fruit. Sugar content is under 1 g. The glycemic index is around 40 (well below the 55 threshold for “low GI”).

This makes them genuinely keto-compatible (nearly 75 percent of calories come from fat, mostly monounsaturated) and well-suited to most low-carb approaches. They’re also one of the few foods that simultaneously satisfies low-carb, anti-inflammatory, Mediterranean, and DASH frameworks.

For a longevity practice that cycles between metabolic states (mTOR/AMPK, fed/fasted, lower-carb/higher-carb), avocados travel well across phases — they don’t disrupt ketosis, they don’t spike insulin, and they don’t require dietary categorization gymnastics.

What About Oxalates?

The “avocados are very high in oxalates” claim is one of those internet truisms that doesn’t survive a careful look at the numbers. The Harvard oxalate database lists a medium avocado at 19 mg of oxalate and labels it “very high.” But the label refers to concentration relative to other foods on the list, not to absolute risk for kidney stone formation. The standard kidney-stone-prevention guideline is to keep total oxalate intake under 100 mg per day for at-risk individuals (under 50 mg for very high risk).

A medium avocado at 19 mg uses less than 20 percent of that budget. Half an avocado, around 8 to 9 mg, is well within “low oxalate” territory by most working definitions (under 5 mg is “low,” 5 to 15 mg is “moderate”). Hass avocados appear to be lower than other varieties, and ripeness reduces oxalate content further.

For most people, avocado oxalate is a non-issue. For those with active kidney stones or hyperoxaluria, half an avocado per day is generally considered safe within a properly managed low-oxalate budget. The “very high” label is misleading.

FODMAPs: A 2024 Surprise

One of the more interesting recent findings: in 2024, Monash University (the global authority on FODMAP research) re-tested avocados and discovered the polyol responsible for digestive symptoms in sensitive people is not sorbitol — as had been assumed for over fifteen years — but perseitol, a seven-carbon sugar alcohol unique to avocados. Perseitol is larger than sorbitol and may have somewhat different gut effects, though the practical recommendation hasn’t dramatically changed.

The current Monash threshold: about 30 g (1/8 of an avocado) is low FODMAP; 1/4 to 1/2 an avocado is high enough to provoke symptoms in IBS-prone individuals. Ripe avocados have less perseitol than unripe ones, which is consistent with the broader pattern of fruit ripening reducing fermentable compounds.

If you don’t have IBS and don’t notice digestive issues, none of this is relevant. If you do, smaller portions and ripe fruit will likely be tolerated better than the “avocado toast with a whole half avocado” approach.

Persin and Unripe Avocados

Persin is a real fungicidal compound found throughout the avocado tree. In leaves and bark, concentrations are toxic enough to be dangerous to birds, horses, and some other animals. In the ripe pulp, persin levels are 50 to 100 times lower and considered safe for non-allergic humans.

Unripe pulp has somewhat higher levels and is the source of the bitter, chalky taste of an underripe avocado, but no clinical reports document persin toxicity from eating ripe or modestly underripe avocado flesh in normal quantities.

One genuine note for some readers: persin appears to enhance the cytotoxic effect of tamoxifen in vitro. People taking tamoxifen for breast cancer treatment may want to discuss avocado intake with their oncologist — not because it’s clearly contraindicated, but because the interaction hasn’t been studied in humans and warrants caution.

Latex-Fruit Syndrome and Allergy

About 30 to 50 percent of people with latex allergy have cross-reactivity to avocado, banana, kiwi, and chestnut due to similar protein structures. True avocado allergy without latex involvement is rare but real. Symptoms range from oral itching to anaphylaxis in severe cases.

Pesticide Load

Avocados are consistently on the EWG’s “Clean Fifteen” list — among the lowest-pesticide-residue produce items, largely because the thick skin protects the flesh. Organic isn’t strongly necessary here from a pesticide standpoint, though there are environmental and labor reasons some people prefer it.

Practical Synthesis

For a longevity-oriented practice, the evidence supports something like this:

Avocados are a high-quality replacement food. They reliably do useful work — modest LDL reduction, improved diet quality, enhanced absorption of fat-soluble nutrients from the rest of the meal, satiety from fiber and fat — when they take the place of heavily processed foods which are full of rancid seed oils.

They are not a “longevity drug” disguised as a fruit.

The SIRT1 activation is real but not the lifespan-relevant pathway. The leukemia story is a real but unfinished research line.
It suggests that taking supplements derived from certain compounds in avocados might be useful under some circumstances, but it’s not in itself a reason to add avocados to your diet.

A reasonable serving for most longevity-focused adults is between half and one whole avocado per day, with smaller portions for those with IBS or kidney stones.

High-quality cold-pressed avocado oil for dressings is a sensible secondary use, but should be avoided unless you are 100% certain that it is an adulterated and fresh. It has most of the compounds that have been found to be beneficial, but is lacking fiber.

If you don’t enjoy avocados, there’s no reason to add them to your diet. If you’re already using olive oil, and are sure that it is fresh and unadulterated, you are already getting the same monounsaturated-fat, phytosterol, fiber, and carotenoids. Avocados are convenient and pleasant — not unique.

A Note on the Quality of the Evidence

It’s worth noting this explicitly: a substantial portion of avocado health research is funded by the Hass Avocado Board and similar industry groups.

This doesn’t make the findings wrong, but it does shape which questions get asked and which studies end up getting published. The 2022 HAT trial, which produced the most cautious results, was actually one of the few large independent randomized controlled trials.

The pattern — heavily promoted modest findings from industry-sponsored work, more sober findings from independent work — is one to keep in mind across the entire field of “superfood” research.

Avocados are (from my perspective) a beneficial food. They are not magic. The honest version of their story is more interesting than the marketing version, and easier to integrate sensibly into a longevity practice.

What I’m doing — and why I’m explicitly not taking an Avo-B supplement.

I do include both avocados and avocado oil in my diet. I use the oil occasionally, not daily. The brand I use is a rich green in color, smells grassy, and comes from a store, which is careful to vet their suppliers.
I was considering trying out a widely-promoted avocatin-B supplement (Metavo). But the label states that it “contains avocatin-B” — but does not say how much. So I’m honestly a little dubious about it.
The research suggests that Avo-B might turn out to be a genuinely beneficial supplement; I would love to find a good source. But at this point, I see no reason to Metavo. If they want to be honest about how much of this key compound is in the supplement, I’ll consider taking their product. Otherwise, as far as I can tell it, it’s the equivalent of eating, 1/4 of an avocado; so I’ll just go on eating avocados. The company is sponsoring a study, so it’s possible that I might change my mind after reading it.
Note: an earlier version of this article had a typo which left out a whole block of words and made it sound like I am taking this supplement; my apologies for any confusion.

Sources include: Cancer Research (2015), Nutrition and Cancer (2025), Journal of the American Heart Association (2022, 2024), Molecular Nutrition and Food Research (2019), Nature (2012), Nature Communications (2021), Advances in Nutrition (2020), Monash University FODMAP research (2024), Journal of Natural Products (analytical methods for AvoB quantification), and the Harvard T.H. Chan School of Public Health Nutrition Source.

Donations support this website

Donations make this website possible.
To donate using Buymeacoffee, please click here.